Search hospitals > California > San Francisco
Kaiser Permanente San Francisco
Claim this profileSan Francisco, California 94115
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Human Immunodeficiency Virus Infection
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
262 reported clinical trials
24 medical researchers
Summary
Kaiser Permanente San Francisco is a medical facility located in San Francisco, California. This center is recognized for care of Cancer, Breast Cancer, Human Immunodeficiency Virus Infection, Lung Cancer, Adenocarcinoma and other specialties. Kaiser Permanente San Francisco is involved with conducting 262 clinical trials across 415 conditions. There are 24 research doctors associated with this hospital, such as Jennifer M. Suga, Samantha A. Seaward, Tatjana Kolevska, MD, and Andrew Rassi, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
Stage II
Top PIs
Jennifer M. SugaKaiser Permanente-Oakland1 year of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
34 reported clinical trials
98 drugs studied
Samantha A. SeawardKaiser Permanente Medical Center - Santa Clara2 years of reported clinical research
Studies Cancer
Studies Breast Cancer
22 reported clinical trials
63 drugs studied
Tatjana Kolevska, MDKaiser Permanente-Vallejo7 years of reported clinical research
Studies Skin Cancer
Studies Melanoma
21 reported clinical trials
51 drugs studied
Andrew Rassi, MDKaiser Permanente San Francisco5 years of reported clinical research
Studies Mitral Valve Regurgitation
Studies Tricuspid Regurgitation
7 reported clinical trials
11 drugs studied
Clinical Trials running at Kaiser Permanente San Francisco
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Cancer
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Squamous Cell Carcinoma
Melanoma
Cutaneous Melanoma
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Kaiser Permanente San Francisco?
Kaiser Permanente San Francisco is a medical facility located in San Francisco, California. This center is recognized for care of Cancer, Breast Cancer, Human Immunodeficiency Virus Infection, Lung Cancer, Adenocarcinoma and other specialties. Kaiser Permanente San Francisco is involved with conducting 262 clinical trials across 415 conditions. There are 24 research doctors associated with this hospital, such as Jennifer M. Suga, Samantha A. Seaward, Tatjana Kolevska, MD, and Andrew Rassi, MD.